Evidence map›Paper›PMID 37240248›Full record

ArticleInternational journal of molecular sciences2023

State of the Art and New Trends from the 2022 Gism Annual Meeting.

Ivana Ferrero, Camilla Francesca Proto, Alessia Giovanna Santa Banche Niclot, Elena Marini, Luisa Pascucci, Filippo Piccinini, Katia Mareschi

Open access · goldAbstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ivana FerreroStem Cell Transplantation and Cellular Therapy Laboratory, Paediatric Onco-Haematology Division, Regina Margherita Childrens' Hospital, City of Health and Science of Turin, 10126 Turin, Italy.
Camilla Francesca ProtoDepartment of Public Health and Paediatrics, University of Turin, 10126 Turin, Italy.ORCID 0009-0001-2053-9519
Alessia Giovanna Santa Banche NiclotDepartment of Public Health and Paediatrics, University of Turin, 10126 Turin, Italy.
Elena MariniDepartment of Public Health and Paediatrics, University of Turin, 10126 Turin, Italy.ORCID 0000-0001-9793-3701
Luisa PascucciDepartment of Veterinary Medicine, University of Perugia, 06125 Perugia, Italy.ORCID 0000-0002-2562-1140
Filippo PiccininiIRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.ORCID 0000-0002-0371-7782
Katia MareschiStem Cell Transplantation and Cellular Therapy Laboratory, Paediatric Onco-Haematology Division, Regina Margherita Childrens' Hospital, City of Health and Science of Turin, 10126 Turin, Italy.ORCID 0000-0003-2889-0394
University of Turin · ITPiedmont Reference Center for Epidemiology and Cancer Prevention · ITIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori · ITUniversity of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 2022 Italian Mesenchymal Stem Cell Group (Gruppo Italiano Staminali Mesenchimali, GISM) Annual Meeting took place on 20-21 October 2022 in Turin (Italy), with the support of the University of Turin and the City of Health and Science of Turin. The novelty of this year's meeting was its articulation, reflecting the new structure of GISM based on six sections: (

Indexed as

Medical OncologyMesenchymal Stem CellsHumansItalyannual meetingconference reportItalian Mesenchymal Stem Cell Group (GISM)mesenchymal stem cells

Identifiers

PMID37240248
PMCPMC10219299
OpenAlexW4377104270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.